Related references
Note: Only part of the references are listed.Slug mediates myofibroblastic differentiation to promote fibrogenesis in buccal mucosa
Chih-Yuan Fang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
LncRNA LINC00974 activates TGF-β/Smad signaling to promote oral fibrogenesis
Chih-Yuan Fang et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2019)
Glabridin inhibits the activation of myofibroblasts in human fibrotic buccal mucosal fibroblasts through TGF-/smad signaling
Ping-Hui Lee et al.
ENVIRONMENTAL TOXICOLOGY (2018)
Inhibitory effect of GMI, an immunomodulatory protein from Ganoderma microsporum, on myofibroblast activity and proinflammatory cytokines in human fibrotic buccal mucosal fibroblasts
Ping-Hui Lee et al.
ENVIRONMENTAL TOXICOLOGY (2018)
Hinokitiol ablates myofibroblast activation in precancerous oral submucous fibrosis by targeting Snail
Hui-Wen Yang et al.
ENVIRONMENTAL TOXICOLOGY (2018)
Butylidenephthalide abrogates the myofibroblasts activation and mesenchymal transdifferentiation in oral submucous fibrosis
Tzu-Rong Su et al.
ENVIRONMENTAL TOXICOLOGY (2018)
miR-200b ameliorates myofibroblast transdifferentiation in precancerous oral submucous fibrosis through targeting ZEB2
Yi-Wen Liao et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
miR-200c inhibits the arecoline-associated myofibroblastic transdifferentiation in buccal mucosal fibroblasts
Ming-Yi Lu et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2018)
Chemosensitizing effect of honokiol in oral carcinoma stem cells via regulation of IL-6/Stat3 signaling
Min-Te Chang et al.
ENVIRONMENTAL TOXICOLOGY (2018)
Natural Products as a Source for Antifibrosis Therapy
Dan-Qian Chen et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
miR-1246 Targets CCNG2 to Enhance Cancer Stemness and Chemoresistance in Oral Carcinomas
Shih-Shen Lin et al.
CANCERS (2018)
Activation of transforming growth factor-1 by thrombin via integrins v1, v3, and v5 in buccal fibroblasts: Suppression by epigallocatechin-3-gallate
Jenny Zwei-Chieng Chang et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2017)
Arctigenin suppresses renal interstitial fibrosis in a rat model of obstructive nephropathy
Ao Li et al.
PHYTOMEDICINE (2017)
Arecoline activates latent transforming growth factor β1 via mitochondrial reactive oxygen species in buccal fibroblasts: Suppression by epigallocatechin-3-gallate
Yu-Ping Hsieh et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2017)
Hinokitiol suppresses cancer stemness and oncogenicity in glioma stem cells by Nrf2 regulation
Wen-Chen Ouyang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: Persistent p27Kip1 induction by interfering with PI3K/Akt/FOXO3a signaling pathway
Ao Li et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Arctigenin suppresses transforming growth factor-β1-induced expression of monocyte chemoattractant protein-1 and the subsequent epithelial-mesenchymal transition through reactive oxygen species-dependent ERK/NF-κB signaling pathway in renal tubular epithelial cells
A. Li et al.
FREE RADICAL RESEARCH (2015)
Arctigenin, a Potent Ingredient of Arctium lappa L., Induces Endothelial Nitric Oxide Synthase and Attenuates Subarachnoid Hemorrhage-Induced Vasospasm through PI3K/Akt Pathway in a Rat Model
Chih-Zen Chang et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Role of Areca Nut Induced TGF-β and Epithelial-Mesenchymal Interaction in the Pathogenesis of Oral Submucous Fibrosis
Ila Pant et al.
PLOS ONE (2015)
Arecoline- induced myofibroblast transdifferentiation from human buccal mucosal fibroblasts is mediated by ZEB1
Yu-Chao Chang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2014)
Activation of TGF-β Pathway by Areca Nut Constituents: A Possible Cause of Oral Submucous Fibrosis
Imran Khan et al.
PLOS ONE (2012)
Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44
Yuejuan Li et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Arecoline-stimulated connective tissue growth factor production in human buccal mucosal fibroblasts: Modulation by curcumin
Yi-Ting Deng et al.
ORAL ONCOLOGY (2009)
Nomenclature and classification of potentially malignant disorders of the oral mucosa
S. Warnakulasuriya et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2007)
Increased plasminogen activator inhibitor-1/tissue type plasminogen activator ratio in oral submucous fibrosis
S-F Yang et al.
ORAL DISEASES (2007)
Identification of arctigenin as an antitumor agent having the ability to eliminate the tolerance of cancer cells to nutrient starvation
S Awale et al.
CANCER RESEARCH (2006)
Arctigenin, a phenylpropanoid dibenzylbutyrolactone lignan, inhibits MAP kinases and AP-1 activation via potent MKK inhibition:: the role in TNF-α inhibition
MK Cho et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2004)
The precancer risk of betel quid chewing, tobacco use and alcohol consumption in oral leukoplakia and oral submucous fibrosis in southern Taiwan
CH Lee et al.
BRITISH JOURNAL OF CANCER (2003)
TGF-β1-mediated fibroblast-myofibroblast terminal differentiation -: the role of Smad proteins
RA Evans et al.
EXPERIMENTAL CELL RESEARCH (2003)
Increased tissue inhibitor of metalloproteinase-1 expression and inhibition of gelatinase A activity in buccal mucosal fibroblasts by arecoline as possible mechanisms for oral submucous fibrosis
YC Chang et al.
ORAL ONCOLOGY (2002)
Share Paper
